Tags : New Zealand

MedTech

Glaukos Expands its Partnership with Santen for Preserflo MicroShunt

Shots: The companies enter into a license agreement for the Preserflo MicroShunt superseding the previous collaboration between the two parties Glaukos get exclusive commercialization rights for the MicroShunt in the US, Australia, New Zealand, Canada, Brazil, Mexico and the remainder of Latin America and gain full control over all development activities for the MicroShunt in […]Read More

Biosimilars

Cipla Expands its Partnership with Alvotech to Commercialize Biosimilars in

Shots: The companies collaborated for marketing and distribution of four biosimilars in Australia and New Zealand Cipla Gulf will be responsible for commercialization of patented biosimilars of the biologic medicine brands, covering therapeutic categories across immunology, osteoporosis, oncology as well as ophthalmology Alvotech will manufacture and develop the products and will be distributed by Cipla […]Read More